Skip to main content
OpenTrials
Completed

NCT Number: NCT00587665

Low Dose Ketamine as an Adjunct to Fentanyl in Outpatient Tonsillectomy

Comparing patients receiving subanesthetic doses of Ketamine vs placebo to see if it can reduce narcotic needs for patients receiving a tonsillectomy and adenoidectomy

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

between 3 and 12 years of age

  • ASA 1 or 2

Exclusion criteria

  • did not consent

Treatment and study plan

ketamine

Drug

Single IV dose of 0.1 mg/kg of ketamine

Placebo

Drug

Saline given of equal volume to drug

Primary outcomes

  1. amount of post op narcotic use

    Time frame: 5 days

Secondary outcomes

  1. degree of nausea and vomiting

    Time frame: 5 days

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

A Prospective Study of Low Dose Ketamine as an Adjunct to Fentanyl in Pediatric Patients Following Outpatient Tonsillectomy and Adenoidectomy

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
Jan 7, 2008
Registry last updated
Jun 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.